Playing the mix-and-match merger and acquisition game is a favorite
pastime of bored med-tech analysts everywhere, and it doesn't hurt that
the combination of below-average deal activity in 2012 and the advent of
the medical device excise tax in 2013 point to more deals on the way.
Today, though, I wonder whether or not a large med-tech company will
step up and acquire privately-held Dune Medical and its potentially revolutionary MarginProbe cancer detection system.
Please read the full article at Seeking Alpha here:
Should Med Tech Head For The Dunes?
No comments:
Post a Comment